REBECCA DELATORRE: Open Payments
NPI 1952992539 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 12 payments from 10 companies in 2025. Trend: 2023 $86 · 2024 $629 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 2 | $36 |
| Novo Nordisk Inc | 1 | $34 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Incyte Corporation | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| LNHC, Inc | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $14 |
Products named: SOFDRA, Wegovy, AKLIEF, LIBTAYO, OPZELURA, COSENTYX, ZELSUVMI, ILUMYA.
Industry payments across CA — which companies pay providers there.
